Why CannTrust (TSX:TRST) Investors Shouldn’t Expect a Miracle

A low share price isn’t enough to make CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) a good buy today and investors that gamble on it could end up losing everything.

little girl in pilot costume playing and dreaming of flying over the sky

Image source: Getty Images

Trying to catch a falling stock can be a very risky proposition. After all, there’s no rule that just because a stock has declined in value that it will return back to where it was before. Even if you wait years, there’s no guarantee that a decline won’t be permanent.

That’s the very real scenario that CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) investors face today: the stock that might be headed toward zero.

Without a significant development, such as Health Canada coming to a decision that isn’t likely to result in the suspension of CannTrust’s license, there’s not much hope for the stock to go anywhere but down.

Stock is a very risky, speculative buy today

Whether technical indicators suggest the stock is a buy, or whether the share price is trading at lower multiples of sales or book value, that alone won’t be enough to guarantee that the stock will bounce back.

The risk is enormous, and investors still holding onto the stock face the very real scenario that they could end up losing all of their money.

While speculators could impact the share price over the short term — and we’ve seen CannTrust’s stock get a bump when the company announced it was getting rid of its CEO — the factors weighing down the stock aren’t going anywhere and could ultimately get stronger.

In some situations, after a scandal hits could be a good time to buy a stock on a very big dip in price, but that’s only the case when there’s a likelihood that the stock will recover in value.

When there’s a fundamental problem with its business that will affect its ability to continue functioning, it’s a very different scenario altogether.

If a company has no real prospects to be able to generate cash flow, there’s going to be no reason to invest in the stock and it becomes purely speculative.

The danger when it comes to speculation is that for a stock that might not have much of a future, it’s akin to going to a casino with your money.

At that point, it becomes more about gambling than investing, and that’s what individuals owning CannTrust shares could find themselves doing today.

Bottom line

Price alone shouldn’t be a reason to buy, hold or sell a stock. Whether CannTrust is trading at $3, $2 or even $1, investors are still putting themselves at significant risk.

The only way CannTrust’s stock could generate value for investors is with a miracle where the company is able to avoid significant punishment given its very public violation of Health Canada’s cannabis rules.

There’s no way to predict how Health Canada will act given the lack of precedents, but there’s a lot more reason to believe that the regulator will come down hard on CannTrust than it going lightly on the cannabis operator. That makes CannTrust a strong sell, regardless of price.

Ultimately, there are much better stocks for investors to choose from today, and CannTrust is simply not worth the significant risk involved.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »